SK CHEMICALS CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58,400 KRW | -0.17% |
|
+3.36% | -13.22% |
| Sales 2022 | 1,829B 1.34B | Sales 2023 | 1,749B 1.28B | Capitalization | 1,219B 890M |
|---|---|---|---|---|---|
| Net income 2022 | 191B 140M | Net income 2023 | 39.86B 29.1M | EV / Sales 2022 | 0.19 x |
| Net cash position 2022 | 993B 725M | Net cash position 2023 | 491B 358M | EV / Sales 2023 | 0.42 x |
| P/E ratio 2022 |
8.23
x | P/E ratio 2023 |
32.5
x | Employees | 1,221 |
| Yield 2022 |
2.05% | Yield 2023 |
-
| Free-Float | 61.63% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.17% | ||
| 1 week | +3.36% | ||
| Current month | -6.26% | ||
| 1 month | -10.43% | ||
| 3 months | -9.60% | ||
| 6 months | +2.46% | ||
| Current year | -13.22% |
1 week
55 300.00
58 800.00
1 month
55 300.0065 200.00
Current year
55 300.0074 100.00
1 year
55 300.0082 000.00
3 years
55 300.00228 666.67
5 years
26 533.33311 333.33
10 years
26 533.33311 333.33
| Managers | Title | Age | Since |
|---|---|---|---|
Cheol Kim
CEO | Chief Executive Officer | 62 | 17-11-30 |
Gwang-Hyun Jeon
CEO | Chief Executive Officer | 59 | - |
Jae-Young Choi
DFI | Director of Finance/CFO | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gwang-Hyun Jeon
CEO | Chief Executive Officer | 59 | - |
Cheol Kim
CEO | Chief Executive Officer | 62 | 17-11-30 |
Yang-Ho Ahn
BRD | Director/Board Member | 67 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 58,400 | -0.17% | 13,192 |
| 24-04-22 | 58,500 | +5.41% | 48,544 |
| 24-04-19 | 55,500 | -2.63% | 59,938 |
| 24-04-18 | 57,000 | +0.35% | 13,381 |
| 24-04-17 | 56,800 | +0.53% | 17,933 |
End-of-day quote Korea S.E., April 22, 2024
More quotes
SK Chemicals Co Ltd is a Korea-based company mainly engaged in the production and sale of chemicals. The Company operates its business through two segments. The Green Chemical segment is engaged in the manufacture and sale of products such as bio copolyester resins, copolyester resins, polyethylene terephthalate (PET) resins, biodiesels, and bio heavy oil. The Life Sciences segment is engaged in the manufacture and sale of medicines, vaccines, and blood products. The Company sells products in domestic and overseas markets such as the United States, Europe, China, Japan, and Singapore.
Sector
Commodity Chemicals
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.22% | 771M | |
| +3.46% | 39.9B | |
| -25.45% | 20.56B | |
| -12.75% | 13.5B | |
| -11.88% | 9.86B | |
| -7.50% | 9.84B | |
| -7.68% | 6.38B | |
| -0.87% | 6.18B | |
| -31.34% | 5.26B | |
| -15.05% | 3.68B |
- Stock Market
- Equities
- A285130 Stock
